Analyst Consensus ?
ConsensusHold75 ratings
Bullish3445.3%
Neutral3952.0%
Bearish22.7%
FN2 Earnings Intelligence
Expedia Group, Inc. (EXPE) analyst consensus, price targets, and firm-level rating history from FN2 Research.
Latest persisted target per named analyst; persisted previous close from FN2's market snapshot as of Jul 30, 2026. Not an FN2 forecast.
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Baird | Outperform | Outperform | Maintain | Jul 22, 2026 |
| Jefferies | Buy | Buy | Maintain | Jul 14, 2026 |
| Argus Research | Buy | Buy | Maintain | Jul 7, 2026 |
| Wells Fargo | Equal Weight | Equal Weight | Maintain | Jun 30, 2026 |
| BTIG | Buy | Buy | Maintain | Jun 9, 2026 |
| DA Davidson | Neutral | Neutral | Maintain | May 18, 2026 |
| Susquehanna | Neutral | Neutral | Maintain | May 11, 2026 |
| Barclays | Equal Weight | Equal Weight | Maintain | May 11, 2026 |
| UBS | Neutral | Neutral | Maintain | May 8, 2026 |
| Piper Sandler | Neutral | Neutral | Maintain | May 8, 2026 |
| B. Riley Securities | Buy | Buy | Maintain | Apr 27, 2026 |
| Truist Securities | Hold | Hold | Maintain | Apr 6, 2026 |
| Morgan Stanley | Equal Weight | Equal Weight | Maintain | Mar 27, 2026 |
| Mizuho | Neutral | Neutral | Maintain | Mar 3, 2026 |
| Wedbush | Neutral | Neutral | Maintain | Feb 17, 2026 |
| Citizens | Market Perform | Market Perform | Maintain | Feb 17, 2026 |
| BMO Capital | Market Perform | Market Perform | Maintain | Feb 17, 2026 |
| TD Cowen | Hold | Hold | Maintain | Feb 13, 2026 |
| Benchmark | Buy | Buy | Maintain | Feb 13, 2026 |
| Goldman Sachs | Buy | Buy | Maintain | Jan 28, 2026 |
| Bernstein | Market Perform | Market Perform | Maintain | Jan 6, 2026 |
| B of A Securities | Buy | Buy | Maintain | Dec 19, 2025 |
| Citigroup | Neutral | Neutral | Maintain | Nov 11, 2025 |
| RBC Capital | Sector Perform | Sector Perform | Maintain | Nov 7, 2025 |
| JP Morgan | Neutral | Neutral | Maintain | Nov 7, 2025 |
| Evercore ISI Group | Outperform | Outperform | Maintain | Nov 7, 2025 |
| Cantor Fitzgerald | Neutral | Neutral | Maintain | Jul 23, 2025 |
| Oppenheimer | Outperform | Outperform | Maintain | May 9, 2025 |
| JMP Securities | Market Perform | Market Perform | Maintain | Feb 7, 2025 |
| HSBC | Hold | Hold | Maintain | May 7, 2024 |
| Ascendiant Capital | Buy | Buy | Maintain | Dec 29, 2023 |
| Credit Suisse | Outperform | Outperform | Maintain | Aug 4, 2023 |
| Gordon Haskett | Buy | Hold | Upgrade | May 16, 2023 |
| Wolfe Research | Underperform | Peer Perform | Downgrade | Dec 7, 2022 |
| Redburn Partners | Neutral | Buy | Downgrade | Aug 29, 2022 |
| Deutsche Bank | Buy | Buy | Maintain | Aug 1, 2022 |
| Cowen & Co. | Outperform | Outperform | Maintain | Feb 7, 2022 |
| Stifel | Hold | Hold | Maintain | Nov 8, 2021 |
| Atlantic Equities | Neutral | Overweight | Downgrade | Nov 2, 2021 |
| CFRA | Hold | Hold | Maintain | May 21, 2020 |
| Raymond James | Outperform | Outperform | Maintain | Apr 29, 2020 |
| SunTrust Robinson Humphrey | Buy | Buy | Maintain | Apr 13, 2020 |
| Consumer Edge Research | Equal Weight | Equal Weight | Maintain | Nov 18, 2019 |
| Stifel Nicolaus | Hold | Hold | Maintain | Nov 7, 2019 |
| Piper Jaffray | Neutral | Overweight | Downgrade | Nov 7, 2019 |
| Bank of America | Neutral | Buy | Downgrade | Nov 7, 2019 |
| Argus | Buy | Hold | Upgrade | Jul 31, 2019 |
| Telsey Advisory Group | Perform | Market Perform | Maintain | Nov 29, 2018 |
| PiperJaffray | Overweight | Overweight | Maintain | Jul 27, 2018 |
| KeyBanc | Overweight | Overweight | Maintain | Jul 27, 2018 |
| Macquarie | Neutral | Outperform | Downgrade | Mar 15, 2018 |
| MKM Partners | Neutral | Neutral | Maintain | Feb 21, 2018 |
| Needham | Buy | Buy | Maintain | Jan 4, 2017 |
| CLSA | Outperform | Outperform | Maintain | Dec 8, 2016 |
| Pacific Crest | Overweight | Sector Weight | Upgrade | Oct 19, 2016 |
| MoffettNathanson | Buy | Buy | Maintain | Mar 17, 2016 |
| Moffett Nathanson | Buy | Buy | Maintain | Mar 17, 2016 |
| Brean Capital | Buy | Buy | Maintain | Mar 10, 2016 |
| Nomura | Neutral | Neutral | Maintain | Feb 11, 2016 |
| William Blair | Market Perform | Outperform | Downgrade | Nov 5, 2015 |
| Canaccord Genuity | Buy | Buy | Maintain | Sep 17, 2015 |
| Guggenheim | Buy | Buy | Maintain | May 19, 2015 |
| Buckingham Research | Neutral | Neutral | Maintain | Jun 27, 2014 |
| Exane BNP Paribas | Outperform | Outperform | Maintain | Jun 11, 2014 |
| Standpoint Research | Hold | Buy | Downgrade | Oct 31, 2013 |
| FBR Capital | Outperform | Outperform | Maintain | Oct 23, 2013 |
| Janney Capital | Neutral | Neutral | Maintain | Sep 12, 2013 |
| Lazard | Buy | Neutral | Upgrade | Sep 9, 2013 |
| Oddo Securities | Buy | Buy | Maintain | Jul 2, 2013 |
| Ameriprise Financial | Sell | Buy | Downgrade | May 30, 2013 |
| Monness, Crespi, Hardt | Neutral | Buy | Downgrade | Feb 4, 2013 |
| Monness Crespi Hardt | Neutral | Buy | Downgrade | Feb 4, 2013 |
| Ascendiant | Buy | Buy | Maintain | Jan 23, 2013 |
| JG Capital | Overweight | Overweight | Maintain | Dec 5, 2012 |
| Bank oferica | Neutral | Neutral | Maintain | Apr 27, 2012 |
Upside is calculated against the persisted previous close $304.27. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Robert W. Baird | Analyst unavailable | $294 | $264.94 | -3.4% | Jul 22, 2026 |
| Goldman Sachs | Analyst unavailable | $330 | $267.95 | +8.5% | Jul 20, 2026 |
| Cantor Fitzgerald | Deepak Mathivanan | $255 | $265.01 | -16.2% | Jul 20, 2026 |
| Argus Research | Analyst unavailable | $315 | $271.27 | +3.5% | Jul 7, 2026 |
| Wells Fargo | Analyst unavailable | $303 | $265.28 | -0.4% | Jun 30, 2026 |
| Susquehanna | Analyst unavailable | $250 | $229.98 | -17.8% | May 11, 2026 |
| Barclays | Analyst unavailable | $264 | $229.98 | -13.2% | May 11, 2026 |
| UBS | Stephen Ju | $262 | $236.19 | -13.9% | May 8, 2026 |
| Robert W. Baird | Michael Bellisario | $290 | $252.79 | -4.7% | May 8, 2026 |
| Wells Fargo | Analyst unavailable | $307 | $252.79 | +0.9% | May 8, 2026 |
| Piper Sandler | Analyst unavailable | $245 | $252.79 | -19.5% | May 8, 2026 |
| Cantor Fitzgerald | Deepak Mathivanan | $240 | $251.44 | -21.1% | Apr 27, 2026 |
| Morgan Stanley | Brian Nowak | $290 | $225.81 | -4.7% | Mar 27, 2026 |
| D.A. Davidson | Analyst unavailable | $260 | $200.74 | -14.5% | Feb 17, 2026 |
| Susquehanna | Shyam Patil | $240 | $204.98 | -21.1% | Feb 17, 2026 |
| BMO Capital | Brian Pitz | $255 | $212.67 | -16.2% | Feb 17, 2026 |
| Robert W. Baird | Analyst unavailable | $282 | $213.94 | -7.3% | Feb 13, 2026 |
| Deutsche Bank | Analyst unavailable | $244 | $216.34 | -19.8% | Feb 13, 2026 |
| Cantor Fitzgerald | Analyst unavailable | $245 | $214.92 | -19.5% | Feb 13, 2026 |
| UBS | Analyst unavailable | $266 | $227.24 | -12.6% | Feb 13, 2026 |
| Wells Fargo | Ken Gawrelski | $315 | $227.24 | +3.5% | Feb 13, 2026 |
| Barclays | Analyst unavailable | $260 | $227.24 | -14.5% | Feb 13, 2026 |
| Truist Financial | Gregory Miller | $252 | $246.61 | -17.2% | Feb 10, 2026 |
| Wedbush | Analyst unavailable | $260 | $233.01 | -14.5% | Feb 6, 2026 |
| Goldman Sachs | Analyst unavailable | $325 | $269.49 | +6.8% | Jan 27, 2026 |
| Barclays | Trevor Young | $245 | $272.15 | -19.5% | Jan 21, 2026 |
| UBS | Analyst unavailable | $270 | $295.88 | -11.3% | Jan 13, 2026 |
| Wells Fargo | Analyst unavailable | $329 | $301.31 | +8.1% | Jan 9, 2026 |
| Bernstein | Richard Clarke | $256 | $293.3 | -15.9% | Jan 6, 2026 |
| BTIG | Analyst unavailable | $330 | $287.47 | +8.5% | Jan 6, 2026 |
| Wedbush | Analyst unavailable | $290 | $287.89 | -4.7% | Dec 19, 2025 |
| Jefferies | Analyst unavailable | $285 | $278.78 | -6.3% | Dec 11, 2025 |
| D.A. Davidson | Tom White | $294 | $265.12 | -3.4% | Nov 17, 2025 |
| Mizuho Securities | Lloyd Walmsley | $270 | $263.11 | -11.3% | Nov 14, 2025 |
| Truist Financial | Analyst unavailable | $210 | $218.85 | -31.0% | Oct 27, 2025 |
| Wedbush | Analyst unavailable | $230 | $226.14 | -24.4% | Oct 22, 2025 |
| Jefferies | Analyst unavailable | $220 | $215.58 | -27.7% | Oct 17, 2025 |
| Wells Fargo | Analyst unavailable | $212 | $219.23 | -30.3% | Oct 6, 2025 |
| Susquehanna | Shyam Patil | $200 | $192.63 | -34.3% | Aug 11, 2025 |
| Bernstein | Richard Clarke | $210 | $192.63 | -31.0% | Aug 11, 2025 |
| D.A. Davidson | Tom White | $218 | $195.5 | -28.4% | Aug 11, 2025 |
| Bernstein | Richard Clarke | $215 | $195.26 | -29.3% | Aug 10, 2025 |
| BTIG | Jake Fuller | $250 | $195.26 | -17.8% | Aug 8, 2025 |
| Piper Sandler | Thomas Champion | $190 | $195.26 | -37.6% | Aug 8, 2025 |
| Wells Fargo | Ken Gawrelski | $211 | $195.26 | -30.7% | Aug 8, 2025 |
| Cantor Fitzgerald | Deepak Mathivanan | $200 | $190.73 | -34.3% | Jul 23, 2025 |
| Wells Fargo | Ken Gawrelski | $143 | $137.11 | -53.0% | Apr 7, 2025 |
| Barclays | Trevor Young | $166 | $182.33 | -45.4% | Jan 13, 2025 |
| D.A. Davidson | Tom White | $190 | $130.01 | -37.6% | Nov 18, 2024 |
| Deutsche Bank | Leo Horowitz | $192 | $186.15 | -36.9% | Nov 8, 2024 |
| Evercore ISI | Mark Mahaney | $210 | $186.46 | -31.0% | Nov 8, 2024 |
| Piper Sandler | Ross Sandler | $153 | $187 | -49.7% | Nov 8, 2024 |
| Truist Financial | Greg Miller | $148 | $150.84 | -51.4% | Oct 17, 2024 |
| BTIG | Jake Fuller | $175 | $148.48 | -42.5% | Sep 27, 2024 |
| B.Riley Financial | Naved Khan | $186 | $137.68 | -38.9% | Sep 3, 2024 |
| Argus Research | John Staszak | $155 | $126.89 | -49.1% | Aug 13, 2024 |
| Piper Sandler | Tom Champion | $140 | $127.26 | -54.0% | Aug 9, 2024 |
| Bank of America Securities | Justin Post | $144 | $117.97 | -52.7% | Aug 9, 2024 |
| Jefferies | John Colantuoni | $125 | $116.02 | -58.9% | May 7, 2024 |
| D.A. Davidson | Tom White | $135 | $116.36 | -55.6% | May 6, 2024 |
| Barclays | Ross Sandler | $138 | $115.33 | -54.6% | May 6, 2024 |
| Evercore ISI | Mark Mahaney | $175 | $136.09 | -42.5% | May 3, 2024 |
| Oppenheimer | Jed Kelly | $155 | $136.09 | -49.1% | May 3, 2024 |
| Mizuho Securities | James Lee | $135 | $136.09 | -55.6% | May 3, 2024 |
| Piper Sandler | Thomas Champion | $145 | $136.09 | -52.3% | May 3, 2024 |
| Wells Fargo | Ken Gawrelski | $155 | $137.75 | -49.1% | Apr 1, 2024 |
| Ascendiant | Edward Woo | $160 | $135.74 | -47.4% | Mar 14, 2024 |
| Goldman Sachs | Eric Sheridan | $195 | $129.7 | -35.9% | Feb 9, 2024 |
| Mizuho Securities | James Lee | $110 | $103.19 | -63.8% | Aug 4, 2023 |
| Wedbush | James Hardiman | $116 | $98.67 | -61.9% | Aug 3, 2023 |
| Barclays | Mario Lu | $124 | $92.63 | -59.2% | Nov 6, 2022 |
| Barclays | Mario Lu | $161 | $106.7 | -47.1% | Aug 24, 2022 |
| Morgan Stanley | Analyst unavailable | $128 | $106.84 | -57.9% | Aug 23, 2022 |
| Deutsche Bank | Lee Horowitz | $130 | $105.65 | -57.3% | Aug 3, 2022 |
| Truist Financial | Naved Khan | $185 | $100.75 | -39.2% | Jul 26, 2022 |
| BTIG | Jake Fuller | $150 | $101.2 | -50.7% | Jun 28, 2022 |
| Truist Financial | Naved Khan | $240 | $106.26 | -21.1% | Jun 14, 2022 |
| Goldman Sachs | Eric Sheridan | $173 | $121.99 | -43.1% | Jun 9, 2022 |
| RBC Capital | Brad Erickson | $185 | $127.79 | -39.2% | May 10, 2022 |
| Credit Suisse | Stephen Ju | $225 | $150.31 | -26.1% | May 3, 2022 |
| D.A. Davidson | Analyst unavailable | $195 | $148.81 | -35.9% | May 3, 2022 |
| Morgan Stanley | Analyst unavailable | $210 | $147.66 | -31.0% | May 3, 2022 |
| Deutsche Bank | Analyst unavailable | $235 | $155.16 | -22.8% | May 3, 2022 |
| Mizuho Securities | Analyst unavailable | $172 | $174.81 | -43.5% | May 3, 2022 |
| Barclays | Analyst unavailable | $229 | $174.81 | -24.7% | May 3, 2022 |
| Piper Sandler | Analyst unavailable | $225 | $174.81 | -26.1% | May 3, 2022 |
| Piper Sandler | Thomas Champion | $225 | $174.81 | -26.1% | May 3, 2022 |
| Barclays | Mario Lu | $229 | $150.31 | -24.7% | May 3, 2022 |
| Jefferies | John Colantuoni | $200 | $150.31 | -34.3% | May 3, 2022 |
| Piper Sandler | Thomas Champion | $225 | $150.31 | -26.1% | May 3, 2022 |
| D.A. Davidson | Tom White | $195 | $150.31 | -35.9% | May 3, 2022 |
| Evercore ISI | Mark Mahaney | $238 | $174.81 | -21.8% | May 2, 2022 |
| Mizuho Securities | James Lee | $172 | $174.81 | -43.5% | May 2, 2022 |
| BTIG | Jake Fuller | $235 | $174.81 | -22.8% | May 2, 2022 |
| BTIG | Jake Fuller | $235 | $174.81 | -22.8% | May 2, 2022 |
| Citigroup | Analyst unavailable | $200 | $190.15 | -34.3% | Apr 20, 2022 |
| Argus Research | John Staszak | $220 | $177.3 | -27.7% | Apr 11, 2022 |
| Deutsche Bank | Leo Horowitz | $218 | $179.31 | -28.4% | Mar 13, 2022 |
| Susquehanna | Shyam Patil | $210 | $197.17 | -31.0% | Feb 14, 2022 |
| Wolfe Research | Deepak Mathivanan | $210 | $192.12 | -31.0% | Feb 11, 2022 |
| Credit Suisse | Stephen Ju | $231 | $192.12 | -24.1% | Feb 11, 2022 |
| Truist Financial | Naved Khan | $260 | $192.12 | -14.5% | Feb 11, 2022 |
| Goldman Sachs | Eric Sheridan | $220 | $192.12 | -27.7% | Feb 11, 2022 |
| Benchmark Co. | Daniel Kurnos | $265 | $192.12 | -12.9% | Feb 11, 2022 |
| Piper Sandler | Thomas Champion | $231 | $192.12 | -24.1% | Feb 11, 2022 |
| RBC Capital | Brad Erickson | $200 | $192.12 | -34.3% | Feb 11, 2022 |
| Evercore ISI | Mark Mahaney | $238 | $192.12 | -21.8% | Feb 11, 2022 |
| Wells Fargo | Brian Fitzgerald | $250 | $192.12 | -17.8% | Feb 11, 2022 |
| Stifel Nicolaus | Scott Devitt | $215 | $192.12 | -29.3% | Feb 11, 2022 |
| Jefferies | John Colantuoni | $210 | $192.12 | -31.0% | Feb 11, 2022 |
| UBS | Lloyd Walmsley | $183 | $192.12 | -39.9% | Feb 11, 2022 |
| J.P. Morgan | Doug Anmuth | $216 | $192.12 | -29.0% | Feb 11, 2022 |
| Mizuho Securities | James Lee | $155 | $197.52 | -49.1% | Feb 10, 2022 |
| Cowen & Co. | Kevin Kopelman | $200 | $187.35 | -34.3% | Feb 7, 2022 |
| Stifel Nicolaus | Scott Devitt | $190 | $174.42 | -37.6% | Jan 22, 2022 |
| Piper Sandler | Thomas Champion | $216 | $184.4 | -29.0% | Jan 14, 2022 |
| Atlantic Equities | James Cordwell | $180 | $159.84 | -40.8% | Nov 2, 2021 |
| Gordon Haskett Capital Corporation | Robert Mollins | $168 | $148.89 | -44.8% | Aug 6, 2021 |
Track every rating change on EXPE the moment it posts. Free to start.
Start free